Events for “apy”

A cancer therapy put severe rheumatoid arthritis into remission

CAR T-cell therapy dramatically reduced disease activity in six people with severe rheumatoid arthritis that had resisted other treatments, with three achieving medication-free remission.

Best CD rates today, Wednesday, August 26, 2026: Earn up to 4.30% APY

STAT+: Cadre of radiopharmaceuticals experts pushes the bounds in cancer therapy

Researchers believe radiopharmaceuticals have great promise as cancer treatments. But are they using them too timidly?

STAT+: We’re reading about drug pricing deals, a new cancer therapy approval, and more

In today's Pharmalittle newsletter, drug pricing deals, a new cancer therapy approval, and more of the latest pharma headlines.

Best high-yield savings interest rates today, Monday, August 31, 2026: Earn up to 4.15% APY

Canberra's zoo treats its residents to personnalised musical therapy

A music therapist in Australia has been playing for animals at Canberra's zoo for the last five years. It's a relaxing experience for animals and staff alike and the animals all react differently to the music played.

Best CD rates today, Sunday, August 30, 2026: Lock in up to 4.30% APY

Best CD rates today, Monday, August 31, 2026: Lock in up to 4.30% APY

STAT+: FDA approves Roivant therapy for rare autoimmune disease

The FDA approved a new medicine from Roivant and its subsidiary Priovant for the treatment of dermatomyositis, a rare autoimmune disease.

Best CD rates today, Saturday, August 29, 2026: Lock in up to 4.30% APY with a 16- or 18-month CD

Bengaluru: Directorate of Medical Education team inspects ‘missing’ physiotherapy and nursing colleges

However, in its clarification, the RGUHS said that the university has been consistently undertaking necessary verification and communication of institutional details as part of its efforts to maintain accurate and reliable information relating to its affiliated institutions

Best CD rates today, Friday, August 28, 2026: Up to 4.30% APY return available

Best high-yield savings interest rates today, Friday, August 28, 2026: Earn up to 4.15% APY

Virtual cell model could accelerate protein-degrader therapy design

A team of Weill Cornell Medicine investigators has developed a computer model that will help scientists more efficiently develop protein-destroying therapies, a newer type of treatment that is particularly promising for cancer.

Ultragenyx (RARE) Jumped 7.5% on FDA Approval. Can a $2.7 Million Gene Therapy Become a Commercial Success?

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

Article URL: https://www.fda.gov/news-events/press-announcements/fda-approves-first-class-targeted-therapy-metastatic-pancreatic-cancer Comments URL: https://news.ycombinator.com/item?id=49451675 Points: 136 # Comments: 30

Best CD rates today, Tuesday, August 25, 2026: Lock in up to 4.30% APY today with multiple offers

Best high-yield savings interest rates today, Wednesday, August 26, 2026: Earn up to 4.15% APY

This 15-Foot Python Is the First Known Snake to Receive Electrochemotherapy for Cancer. Now, She's Officially Free of the Disease

The pioneering treatment makes it easier for traditional chemotherapy drugs to penetrate cancer cells. After the procedure, the reptile, named Jodie Foster, made a speedy recovery

STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns

The FDA put a hold on a Regenxbio gene therapy trial again after new safety concerns emerged.

STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more

President Trump’s pledge to make pricey weight loss drugs widely available for low-income Americans through Medicaid is not panning out

Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?

Urologic oncologists who treat prostate cancer are split over the benefits of focal therapy compared to traditional surgery or radiation.

When Vocabulary Comprehension Fails Clinical Reasoning: Evaluating Therapy Bots' Safety Risks for Generation Alpha

arXiv:2608.20345v1 Announce Type: new Abstract: Conversational AI systems have become informal mental health support resources for Generation Alpha (Gen Alpha, born 2010-2024), with 13.1% of U.S. adolescents (5.4 million) using generative AI for mental health advice. While these

Accordia Bank is offering a 5.00% APY booster on high-yield savings account for its rebrand — how to get it

Utah residents can snag a 5.00% APY boost as Accordia Bank celebrates its rebrand, while everyone else can still earn a competitive rate.

Best high-yield savings interest rates today, Monday, August 24, 2026: Earn up to 4.15% APY

STAT+: FDA approves Ultragenyx gene therapy

Regeneron wins ultra-rare disease drug approval, a validating win for mRNA research, and more biotech news from The Readout

STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more

A Regeneron drug for an ultra-rare disease that causes bone to grow where it shouldn't won U.S. regulatory approval, capping a three-decade effort

Best CD rates today, Sunday, August 23, 2026: Lock in up to 4.35% APY

Best CD rates today, Monday, August 24, 2026: Lock in up to 4.35% APY

Best CD rates today, Saturday, August 22, 2026: Best CD account earns 4.35% APY

Doctors achieve new feat in cancer treatment with cord transplant and Car T-cell therapy

Doctors at Narayana Health have reported two medical breakthroughs: a seven-year-old thalassaemia patient is now transfusion-free after a Haplo-cord transplant, while a 62-year-old brain cancer patient responded to dual-target CAR-T cell therapy

In ‘Fires in the Dark,’ Kay Redfield Jamison Turns to Healers

In “Fires in the Dark,” Jamison, known for her expertise on manic depression, delves into the quest to heal. Her new book, she says, is a “love song to psychotherapy.”

Briefing Chat: How Dolly Parton left her mark on science

Nature, Published online: 28 August 2026; doi:10.1038/d41586-026-02732-w Nature reporters discuss the country-music icon's advocacy for vaccines and public health — plus, promising trial results for an mRNA cancer therapy.

Experimental eye drops help blind mice see again

Scientists have created light-activated drugs that helped blind mice perceive light again and restored visually guided behavior without gene therapy, implants, or specialized lighting.

Hitting bacteria hard and early with diverse phage cocktails may curb resistance

As multidrug antibiotic resistance emerges as a potent public health challenge, medical science has renewed attention on the potential for bacteriophage therapy.

Paris Jackson underwent ECT for severe depression. Here’s why the treatment remains debated

Electroconvulsive therapy is supposed to be used only in extreme circumstances, such as when a patient is suicidal or when other treatments have failed.

The brain struggles to make new neurons in people with depression

Nature, Published online: 25 August 2026; doi:10.1038/d41586-026-02661-8 High resolution, wide-coverage map of the hippocampus reveals possible pathways for therapy.

STAT+: FDA approves new pancreatic cancer drug expected to usher in new era of treatment

The FDA has approved a life-extending treatment for advanced pancreatic cancer — the first such therapy to attack a genetic cause of the highly lethal malignancy.

Spiraling health costs force Iranians to delay care

A single chemotherapy session in Iran can cost six times the monthly minimum wage. As drug prices soar and medicine is in short supply, doctors say more patients are delaying or abandoning treatment.

Scientists deploy Merck’s Ebola vaccine in DRC

Prostate cancer therapy, Meta glasses in hospital settings, and more health news from Morning Rounds

London Zoo animals hop on scales for weigh-in

Kiwi the Capybara is among animals getting their annual health check while data is gathered and shared.

Iran's medicine crisis prices patients out of treatment

A single chemotherapy session in Iran can cost six times the monthly minimum wage. As drug prices soar and medicine shortages persist, doctors say more patients are delaying or abandoning treatment they cannot afford.

STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection

Capricor Therapeutics is trying to stave off FDA rejection of its cell therapy for Duchenne muscular dystrophy.